NCT01504906View on ClinicalTrials.gov

Study to Assess Effect of Cyclosporine on the Blood Levels of Ticagrelor

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Healthy

Interventions

DRUG

cyclosporine

Oral tablets, 600 mg , single dose

DRUG

ticagrelor

Oral tablets, 180 mg, single dose

Trial Locations (1)

Unknown

Research site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY